Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis
Status PubMed-not-MEDLINE Language English Country Switzerland Media print-electronic
Document type Journal Article, Review
PubMed
34539317
PubMed Central
PMC8406346
DOI
10.1159/000513123
PII: tmh-0048-0234
Knihovny.cz E-resources
- Keywords
- Adverse events, Apheresis, Diagnoses, Registry,
- Publication type
- Journal Article MeSH
- Review MeSH
UNLABELLED: Therapeutic apheresis (TA) is prescribed to patients that suffer from a severe progressive disease that is not sufficiently treated by conventional medications. A way to gain more knowledge about this treatment is usually by the local analysis of data. However, the use of large quality assessment registries enables analyses of even rare findings. Here, we report some of the recent data from the World Apheresis Association (WAA) registry. Data from >104,000 procedures were documented, and TA was performed on >15,000 patients. The main indication for TA was the collection of autologous stem cells (45% of patients) as part of therapy for therapy. Collection of stem cells from donors for allogeneic transplantation was performed in 11% of patients. Patients with indications such as neurological diseases underwent plasma exchange (28%). Extracorporeal photochemotherapy, lipid apheresis, and antibody removal were other indications. Side effects recorded in the registry have decreased significantly over the years, with approximately only 10/10,000 procedures being interrupted for medical reasons. CONCLUSION: Collection of data from TA procedures within a multinational and multicenter concept facilitates the improvement of treatment by enabling the analysis of and feedback on indications, procedures, effects, and side effects.
Apheresis Center North Rostock Germany
Apheresis Center University Hospital Lund Sweden
Apheresis Center University Hospital Orebro Sweden
Apheresis Unit Coimbra University Hospital Coimbra Portugal
Apheresis Unit Haematological AKH Vienna Austria
Apheresis Unit Renal AKH Vienna Austria
Apheresis Unit University Hospital Ostrava Czechia
Banc de Sang i Teixits Hospital Bellvitge Barcelona Spain
Blood Center University Uppsala Sweden Uppsala Sweden
Bone Marrow Transplant and Apheresis Concord New South Wales Australia
Center for Immunology and Transfusion Akers University Hospital Loerenskog Norway
Clinical Immunology and Transfusion Medicine Linköping University Linköping Sweden
Department Haematology University Hospital Ankara Turkey
Department of Hematology AZ Delta Roeselare Belgium
Department of Nephrology Karlstad Sweden
Department of Nephrology Skaraborg Hospital Skövde Sweden
Department of Nephrology University Hospital Ghent Belgium
Department of Nephrology University Hospital Huddinge Sweden
Department of Nephrology University Hospital Skopje North Macedonia
Department of Nephrology University Hospital Uppsala Sweden
Institute for Endocrinology University Hospital Belgrade Serbia
Institute of Hematology and Blood Transfusion Prague Czechia
Italian National Blood Centre National Institute of Health Rome Italy
Nephrology Rheumatology Blood Purification Academic Teaching Hospital Braunschweig Germany
Public Health and Clinical Medicine Umeå University Umeå Sweden
Sanquin Blood Supply Amsterdam The Netherlands
South African National Blood Service Johannesburg South Africa
St Anna Pediatric Department Vienna Austria
Therapeutic Apheresis Unit University Hospital Vilnius Lithuania
Transfusion Medicine and Transplantation Biology University Zagreb Croatia
See more in PubMed
Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016 Jun;31((3)):149–62. PubMed
De Silvestro G. The Italian registry of therapeutic apheresis − 2015. Transfus Apheresis Sci. 2017 Feb;56((1)):75–81. PubMed
De Silvestro G, Tison T. Italian Society of A, Cell M. Italian Registry of Therapeutic Apheresis. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2018;57((2)):143–147. PubMed
Mörtzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, Eloot S, et al. Adverse events in apheresis: an update of the WAA registry data. Transfus Apheresis Sci. 2016 Feb;54((1)):2–15. PubMed
Stegmayr B, Mortzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, et al. Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2017 PubMed
Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019 Jun;34((3)):171–354. PubMed
Stegmayr BG, Ivanovich P, Korach JM, Rock G, Norda R, Ramlow W. World apheresis registry. J Clin Apher. 2005 Jul;20((2)):126–7. PubMed
Stegmayr BG, Ivanovich P, Korach JM, Rock G, Norda R, Ramlow W. World apheresis association—world apheresis registry. Transfus Apheresis Sci. 2005 Apr;32((2)):205–7. PubMed
Stegmayr B, Korach JM, Norda R, Rock G, Fadel F. Is there a need for a national or a global apheresis registry? Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2003;29((2)):179–85. PubMed
Stegmayr B. The World Apheresis Association Registry. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2017 PubMed
Stegmayr B, Ptak J, Wikstrom B. World apheresis registry report. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2007;36((1)):13–6. PubMed
Stegmayr B, Ptak J, Wikström B, Berlin G, Axelsson CG, Griskevicius A, et al. World apheresis registry 2003-2007 data. Transfus Apheresis Sci. 2008 Dec;39((3)):247–54. PubMed
Witt V, Stegmayr B, Ptak J, Wikström B, Berlin G, Axelsson CG, et al. World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfus Apheresis Sci. 2008 Dec;39((3)):255–60. PubMed
Bláha M, Pták J, Cáp J, Ceeová V, Masín V, Filip S, et al. WAA apheresis registry in the Czech Republic: two centers experience. Transfus Apheresis Sci. 2009 Aug;41((1)):27–31. PubMed
Blaha M, Ptak J, Cap J, Ceeova V, Masin V, Filip S, et al. WAA apheresis registry in the Czech Republic: two centers experience. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2009;41((1)):27–31. PubMed
Mortzell M, Berlin G, Nilsson T, Axelsson CG, Efvergren M, Audzijoni J, et al. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2011;45((2)):125–31. PubMed
Stegmayr B, Ptak J, Nilsson T, Berlin G, Mirea V, Axelsson CG, et al. Panorama of adverse events during cytapheresis. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2013;48((2)):155–6. PubMed
Norda R, Axelsson CG, Axdorph U, Berlin G, Wikström B, Stegmayr B, Swedish Apheresis Group Recognition of intercenter differences may help develop best practice. Ther Apher Dial. 2008 Oct;12((5)):347–54. PubMed
Bing-Lei W, Jia-Hua Z, Yan L, Zan Y, Xin B, Jian-Hua S, et al. Three cases of antibody-LGI1 limbic encephalitis and review of literature. Int J Neurosci. 2019 Jul;129((7)):642–8. PubMed
Esposito S, Principi N, Calabresi P, Rigante D. An evolving redefinition of autoimmune encephalitis. Autoimmun Rev. 2019 Feb;18((2)):155–63. PubMed
Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, et al. European Vasculitis Study Group (EUVAS) Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. Ann Rheum Dis. 2019 Mar;78((3)):399–405. PubMed
McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant. 2019 Jan;34((1)):63–73. PubMed PMC
Patterson K, Iglesias E, Nasrallah M, González-Álvarez V, Suñol M, Anton J, et al. Anti-MOG encephalitis mimicking small vessel CNS vasculitis. Neurol Neuroimmunol Neuroinflamm. 2019 Feb;6((2)):e538. PubMed PMC
Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, et al. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2019 Feb;58((2)):260–8. PubMed
Si Z, Wang A, Liu J, Zhang Z, Hu K. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review. Neurol Sci. 2019 Apr;40((4)):769–77. PubMed
Strunk D, Schmidt-Pogoda A, Beuker C, Milles LS, Korsukewitz C, Meuth SG, et al. Biomarkers in Vasculitides of the Nervous System. Front Neurol. 2019 Jun;10:591. PubMed PMC
Stuhlmüller B, Schneider U, González-González JB, Feist E. Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies. Front Neurol. 2019 May;10:438. PubMed PMC
Norda R, Berséus O, Stegmayr B. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apheresis Sci. 2001 Aug;25((1)):33–41. PubMed
Norda R, Knutson F, Berseus O, Akerblom O, Nilsson-Ekdahl K, Stegmayr B, et al. Unexpected effects of donor gender on the storage of liquid plasma. Vox Sang. 2007 Oct;93((3)):223–8. PubMed
Norda R, Schött U, Berséus O, Akerblom O, Nilsson B, Ekdahl KN, et al. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma. Vox Sang. 2012 Feb;102((2)):125–33. PubMed
Norda R, Stegmayr BG, Swedish Apheresis Group Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apheresis Sci. 2003 Oct;29((2)):159–66. PubMed
Norda R, Stegmayr BG, Swedish Apheresis Study Group Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group. Transfus Apheresis Sci. 2001 Feb;24((1)):49–55. PubMed
Stegmayr B, Tärnvik A. Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration. Blood Purif. 1989;7((1)):10–5. PubMed
Toss F, Edgren G, Berlin G, Stegmayr B, Witt V. Does prophylactic calcium in apheresis cause more harm than good? - Centre heterogeneity within the World Apheresis Association Register prevents firm conclusions. Vox Sang. 2018 Oct;113((7)):632–8. PubMed